Skip to content
HowShorted

Avalo Therapeutics, Inc. short interest in 2022

In 2022, Avalo Therapeutics, Inc.'s disclosed short interest ran from 1.77% of shares outstanding on 14 Jan 2022 to 0.37% on 30 Dec 2022, a change of -1.40 percentage points. The year's high was 2.11% on 15 Jun 2022 and its low 0.36% on 15 Nov 2022, averaging 1.06% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.26 days on 31 May 2022. Full history: Avalo Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Avalo Therapeutics, Inc. in 2022

2022 in figures

Start of year
1.77% (14 Jan 2022)
End of year
0.37% (30 Dec 2022)
Change
-1.40 pp
High
2.11% (15 Jun 2022)
Low
0.36% (15 Nov 2022)
Average
1.06%
Highest days to cover
6.26 (31 May 2022)
SEC filings marked
8

Every report in 2022

Avalo Therapeutics, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20221.77%1.74
31 Jan 20221.34%2.10
15 Feb 20221.12%4.58
28 Feb 20221.26%3.27
15 Mar 20221.25%3.6510-K filed, results (8-K)
31 Mar 20221.28%5.52
14 Apr 20221.52%4.21
29 Apr 20221.84%5.35
13 May 20221.84%2.5710-Q filed, results (8-K)
31 May 20221.91%6.26
15 Jun 20222.11%4.14
15 Aug 20220.93%1.0010-Q filed, results (8-K)
31 Aug 20220.56%2.50
15 Sep 20220.71%1.69
30 Sep 20220.47%3.98
14 Oct 20220.52%3.58
31 Oct 20220.37%2.16
15 Nov 20220.36%1.1910-Q filed, results (8-K)
30 Nov 20220.40%5.62
15 Dec 20220.43%5.03
30 Dec 20220.37%2.69

See also: Avalo Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.